|131.96||+0.8300||+0.63%||Vol 1.54M||1Y Perf -3.87%|
|Mar 24th, 2023 16:03 DELAYED|
|- -||-0.25 -0.19%|
|Target Price||158.58||Analyst Rating||Strong Buy 1.33|
|Potential %||20.17||Finscreener Ranking||★★ 46.35|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★+ 44.97|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 61.95|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★ 38.79|
|Price Range Ratio 52W %||40.72||Earnings Rating||Sell|
|Market Cap||39.02B||Earnings Date||28th Feb 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Mngmt Effectiveness||Value||Industry||S&P 500||US Markets|
ROE (5Y Avg)
ROE last 12 Months
ROA (5Y Avg)
ROA last 12 Months
ROC (5Y Avg)
ROC last 12 Months
Return on invested Capital Q
Return on invested Capital Y
|Valuation||Value||Industry||S&P 500||US Markets|
|Financial Strength||Value||Industry||S&P 500||US Markets|
|Profitability||Value||Industry||S&P 500||US Markets|
|Revenue||Value||Industry||S&P 500||US Markets|
|Dividends||Value||Industry||S&P 500||US Markets|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||1.30|
|EPS Growth Next 5 Years %||10.00|
|Avg. Weekly Volume||1.78M|
|Avg. Monthly Volume||1.65M|
|Avg. Quarterly Volume||1.33M|
Agilent Technologies Inc. (NYSE: A) stock closed at 131.96 per share at the end of the most recent trading day (a 0.63% change compared to the prior day closing price) with a volume of 1.54M shares and market capitalization of 39.02B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 16700 people. Agilent Technologies Inc. CEO is Michael R. McMullen.
The one-year performance of Agilent Technologies Inc. stock is -3.87%, while year-to-date (YTD) performance is -11.82%. A stock has a five-year performance of 99.76%. Its 52-week range is between 112.52 and 160.265, which gives A stock a 52-week price range ratio of 40.72%
Agilent Technologies Inc. currently has a PE ratio of 35.30, a price-to-book (PB) ratio of 8.24, a price-to-sale (PS) ratio of 6.38, a price to cashflow ratio of 33.80, a PEG ratio of 2.32, a ROA of 12.74%, a ROC of 16.23% and a ROE of 25.30%. The company’s profit margin is 18.35%, its EBITDA margin is 28.60%, and its revenue ttm is $6.85 Billion , which makes it $23.13 revenue per share.
Of the last four earnings reports from Agilent Technologies Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.30 for the next earnings report. Agilent Technologies Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Agilent Technologies Inc. is Strong Buy (1.33), with a target price of $158.58, which is +20.17% compared to the current price. The earnings rating for Agilent Technologies Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Agilent Technologies Inc. has a dividend yield of 0.61% with a dividend per share of $0.90 and a payout ratio of 25.00%.
Agilent Technologies Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 10.10, ATR14 : 3.82, CCI20 : -145.34, Chaikin Money Flow : -0.07, MACD : -3.86, Money Flow Index : 19.33, ROC : -6.34, RSI : 36.86, STOCH (14,3) : 24.22, STOCH RSI : 0.28, UO : 49.28, Williams %R : -75.78), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Agilent Technologies Inc. in the last 12-months were: Dominique Grau (Sold 4 000 shares of value $636 800 ), Heidi Kunz (Sold 3 635 shares of value $566 482 ), Henrik Ancher-Jensen (Sold 29 500 shares of value $4 595 510 ), Jacob Thaysen (Sold 24 653 shares of value $3 555 189 ), Koh Boon Hwee (Sold 13 000 shares of value $1 978 692 ), Michael R. McMullen (Option Excercise at a value of $6 634 121), Michael R. McMullen (Sold 162 601 shares of value $24 732 429 ), Michael Tang (Sold 11 145 shares of value $1 663 375 ), Padraig McDonnell (Sold 9 027 shares of value $1 241 938 ), Rodney Gonsalves (Sold 4 634 shares of value $723 831 )
|Analyst Ratings||Current||1 M ago||3 M ago|
|Summary Rating||Strong Buy||Strong Buy||Strong Buy|
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2020 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (33%) and China (20%) representing the largest country concentrations.
CEO: Michael R. McMullen
Telephone: +1 800 227-9770
Address: 5301 Stevens Creek Boulevard, Santa Clara 95051, CA, US
Number of employees: 16 700
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.